We would love to hear from you. Click on the ‘Contact Us’ link to the right and choose your favorite way to reach-out!

wscdsdc

media/speaking contact

Jamie Johnson

business contact

Victoria Peterson

Contact Us

855.ask.wink

Close [x]
pattern

Industry News

Categories

  • Industry Articles (21,155)
  • Industry Conferences (2)
  • Industry Job Openings (35)
  • Moore on the Market (414)
  • Negative Media (144)
  • Positive Media (73)
  • Sheryl's Articles (800)
  • Wink's Articles (353)
  • Wink's Inside Story (274)
  • Wink's Press Releases (123)
  • Blog Archives

  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • August 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • November 2008
  • September 2008
  • May 2008
  • February 2008
  • August 2006
  • CNO Financial Group Reports First Quarter 2019 Results

    April 30, 2019 by CNO Financial Group

    CARMEL, Ind.April 29, 2019 /PRNewswire/ — CNO Financial Group, Inc. (NYSE: CNO) today announced that for the quarter ending March 31, 2019, net income was $0.32 per diluted share, compared to $0.50 per diluted share in 1Q18.  CNO also reported that 1Q19 net operating income (1) was $0.41 per diluted share, compared to $0.39 in 1Q18 (as adjusted to remove the earnings from the long-term care business that was ceded in 3Q18).

    “For the third consecutive quarter, CNO delivered strong production results in all three of our businesses,” said Gary C. Bhojwani, chief executive officer. “The product development, market access and agent force programs that we have steadily implemented over the last four to six quarters continue to drive growth and consumer value.”

    Highlights

    • First-year collected premiums were up 18% from 1Q18
    • All health benefit ratios were within – or more favorable – than provided guidance
    • Returned $63.4 million to shareholders in the form of share repurchases ($47.0 million) and dividends ($16.4 million)
    • Book value per common share was $23.99 at March 31, 2019
    • Completed Web Benefits Design acquisition (Read the press release here)

    Quarterly Operating Results

    Three months ended

    March 31,

    2019

    2018

    (Dollars in millions, 
    except per share data)

    Net operating income (1)

    $

    65.8

    $

    73.9

    Net realized investment gains (losses) from sales and impairments (net of related amortization)

    (.7)

    .5

    Net change in market value of investments recognized in earnings

    16.6

    (15.7)

    Fair value changes in embedded derivative liabilities (net of related amortization)

    (29.6)

    25.1

    Fair value changes related to agent deferred compensation plan

    (5.3)

    Other

    1.2

    3.3

    Non-operating income (loss) before taxes

    (17.8)

    13.2

    Income tax expense (benefit) on non-operating income

    (3.8)

    2.8

    Net non-operating income (loss)

    (14.0)

    10.4

    Net income

    $

    51.8

    $

    84.3

    Per diluted share:

    Net operating income

    $

    .41

    $

    .44

    Net realized investment gains (losses) from sales and impairments (net of related amortization and taxes)

    Net change in market value of investments recognized in earnings (net of taxes)

    .08

    (.07)

    Fair value changes in embedded derivative liabilities (net of related amortization and taxes)

    (.15)

    .12

    Fair value changes related to agent deferred compensation plan (net of taxes)

    (.03)

    Other

    .01

    .01

    Net income

    $

    .32

    $

    .50

    Please refer to our 1Q2019 Quarterly Financial Supplement for additional information related to the Company’s financial and reporting results for the quarter ended March 31, 2019.  Such information was furnished as an exhibit to our Current Report on Form 8-K dated April 29, 2019.

    Significant Items Impacting Net Operating Income

    Three months ended

    March 31,

    2019

    2018

    Dollars in

    Per diluted

    Dollars in

    Per diluted

    millions

    share

    millions

    share

    Net operating income (1)

    $

    65.8

    $

    .41

    $

    73.9

    $

    .44

    Earnings on long-term care ceded block

    (8.2)

    (.05)

    Net operating earnings, excluding the earnings on the long-term care ceded block

    65.8

    .41

    65.7

    .39

    Significant items identified in prior year press release

    (.9)

    (.01)

    Net operating earnings, excluding significant items and the earnings on the long-term care ceded block

    $

    65.8

    $

    .41

    $

    64.8

    $

    .38

    In 3Q18, we ceded the Bankers Life legacy long-term care business under a 100% indemnity coinsurance agreement.  In the above table, we have adjusted the operating earnings, excluding significant items, in 1Q18 to remove the earnings of this block.

    There were no significant items in 1Q19.  The significant items in 1Q18 included: (i) a $2.3 million release of long-term care reserves (net of the reduction in insurance intangibles) due to the impact of policyholder actions following rate increases; (ii) a $1.1 million out-of-period adjustment which increased reserves on closed block annuities; and (iii) an increase in tax expense of $.3 million.

    Non-Operating Items

    Net realized investment losses in 1Q19 were $.7 million (net of related amortization) including other-than-temporary impairment losses of $2.2 million which were recorded in earnings.  Net realized investment gains in 1Q18 were $.5 million (net of related amortization).  There were no other-than-temporary impairment losses recognized in 1Q18.

    During 1Q19 and 1Q18, we recognized an increase (decrease) in earnings of $16.6 million and $(15.7) million, respectively, due to the net change in market value of investments recognized in earnings.

    During 1Q19 and 1Q18, we recognized an increase (decrease) in earnings of $(29.6) million and $25.1 million, respectively, resulting from changes in the estimated fair value of embedded derivative liabilities related to our fixed index annuities, net of related amortization.  Such amounts include the impacts of changes in market interest rates used to determine the derivative’s estimated fair value.

    In 1Q19, we recognized a decrease in earnings of $5.3 million for the mark-to-market change in the agent deferred compensation plan liability which was impacted by changes in the underlying actuarial assumptions used to value the liability.  We recognize the mark-to-market change in the estimated value of this liability through earnings as assumptions change.

    Statutory (based on non-GAAP measures) and GAAP Capital Information

    Our consolidated statutory risk-based capital ratio was estimated at 416% at March 31, 2019, reflecting estimated 1Q19 statutory operating income of $83 million and the payment of insurance company dividends to the holding company of $41.0 million during 1Q19.

    During the first quarter of 2019, we repurchased $47.0 million of common stock under our securities repurchase program (including $6.0 million of repurchases settled in 2Q19).  We repurchased 2.9 million common shares at an average cost of $16.25 per share.  As of March 31, 2019, we had 160.0 million shares outstanding and had authority to repurchase up to an additional $237.6 million of our common stock.  During 1Q19, dividends paid on common stock totaled $16.4 million.

    Unrestricted cash and investments held by our holding company were $230 million at March 31, 2019, compared to $220 million at December 31, 2018.

    Book value per common share was $23.99 and $20.78 at March 31, 2019 and December 31, 2018, respectively.  Book value per diluted share, excluding accumulated other comprehensive income (loss) (2), was $19.76 at March 31, 2019, compared to $19.52 at December 31, 2018.

    The debt-to-capital ratio was 19.3 percent and 21.4 percent at March 31, 2019 and December 31, 2018, respectively.  Our debt-to-total capital ratio, excluding accumulated other comprehensive income (3) was 22.4 percent at March 31, 2019 compared to 22.3 percent at December 31, 2018.

    Other Announcements

    CNO also announced today that it has acquired privately-owned Web Benefits Design Corporation, a leading on-line benefits administration firm.  Please refer to today’s separate release for additional information.

    Conference Call

    The Company will host a conference call to discuss results on April 30, 2019 at 10:00 a.m. Eastern Daylight Time.  The webcast can be accessed through the Investors section of the company’s website: http://ir.CNOinc.com.  Participants should go to the website at least 15 minutes before the event to register and download any necessary audio software.  During the call, we will be referring to a presentation that will be available the morning of the call at the Investors section of the company’s website.

    About CNO Financial Group

    CNO Financial Group, Inc. (NYSE: CNO) is a holding company.  Our insurance companies – principally Bankers Life and Casualty Company, Colonial Penn Life Insurance Company and Washington National Insurance Company – primarily serve middle-income pre-retiree and retired Americans by helping them protect against financial adversity and provide for a more secure retirement.  For more information, visit CNO online at www.CNOinc.com.

    CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

    CONSOLIDATED BALANCE SHEET

    (Dollars in millions)

    (unaudited)

    March 31,
    2019

    December 31, 
    2018

    ASSETS

    Investments:

    Fixed maturities, available for sale, at fair value (amortized cost: March 31, 2019 – $18,477.5; December 31, 2018 – $18,107.8)

    $

    19,468.4

    $

    18,447.7

    Equity securities at fair value (cost: March 31, 2019 – $42.2; December 31, 2018 – $319.8)

    40.8

    291.0

    Mortgage loans

    1,626.1

    1,602.1

    Policy loans

    121.3

    119.7

    Trading securities

    237.9

    233.1

    Investments held by variable interest entities

    1,241.4

    1,468.4

    Other invested assets

    943.3

    833.4

    Total investments

    23,679.2

    22,995.4

    Cash and cash equivalents – unrestricted

    621.6

    594.2

    Cash and cash equivalents held by variable interest entities

    69.7

    62.4

    Accrued investment income

    214.8

    205.2

    Present value of future profits

    333.6

    343.6

    Deferred acquisition costs

    1,289.1

    1,322.5

    Reinsurance receivables

    4,879.7

    4,925.4

    Income tax assets, net

    479.9

    630.0

    Assets held in separate accounts

    4.9

    4.4

    Other assets

    741.9

    356.7

    Total assets

    $

    32,314.4

    $

    31,439.8

    LIABILITIES AND SHAREHOLDERS’ EQUITY

    Liabilities:

    Liabilities for insurance products:

    Policyholder account balances

    $

    11,658.2

    $

    11,594.1

    Future policy benefits

    11,252.9

    11,082.4

    Liability for policy and contract claims

    521.0

    521.9

    Unearned and advanced premiums

    255.9

    253.9

    Liabilities related to separate accounts

    4.9

    4.4

    Other liabilities

    804.0

    632.4

    Investment borrowings

    1,645.5

    1,645.8

    Borrowings related to variable interest entities

    1,416.8

    1,417.2

    Notes payable – direct corporate obligations

    917.3

    916.8

    Total liabilities

    28,476.5

    28,068.9

    Commitments and Contingencies

    Shareholders’ equity:

    Common stock ($0.01 par value, 8,000,000,000 shares authorized, shares issued and outstanding: March 31, 2019 – 159,955,172; December 31, 2018 – 162,201,692)

    1.6

    1.6

    Additional paid-in capital

    2,952.2

    2,995.0

    Accumulated other comprehensive income

    654.9

    177.7

    Retained earnings

    229.2

    196.6

    Total shareholders’ equity

    3,837.9

    3,370.9

    Total liabilities and shareholders’ equity

    $

    32,314.4

    $

    31,439.8

    CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

    CONSOLIDATED STATEMENT OF OPERATIONS

    (Dollars in millions, except per share data)

    (unaudited)

    Three months ended

    March 31,

    2019

    2018

    Revenues:

    Insurance policy income

    $

    619.3

    $

    659.9

    Net investment income:

    General account assets

    270.6

    329.1

    Policyholder and other special-purpose portfolios

    85.2

    12.8

    Realized investment gains (losses):

    Net realized investment gains (losses), excluding impairment losses

    18.3

    (15.2)

    Impairment losses recognized (a)

    (2.2)

    Total realized gains

    16.1

    (15.2)

    Fee revenue and other income

    31.8

    21.2

    Total revenues

    1,023.0

    1,007.8

    Benefits and expenses:

    Insurance policy benefits

    623.5

    586.6

    Interest expense

    41.0

    33.6

    Amortization

    58.2

    71.9

    Other operating costs and expenses

    234.7

    207.6

    Total benefits and expenses

    957.4

    899.7

    Income before income taxes

    65.6

    108.1

    Income tax expense on period income

    13.8

    23.8

    Net income

    $

    51.8

    $

    84.3

    Earnings per common share:

    Basic:

    Weighted average shares outstanding

    160,948,000

    167,060,000

    Net income

    $

    .32

    $

    .50

    Diluted:

    Weighted average shares outstanding

    162,189,000

    169,677,000

    Net income

    $

    .32

    $

    .50

    ______________

    (a)

    No portion of the other-than-temporary impairments recognized in the periods was included in accumulated other comprehensive income.

    CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

    FIRST-YEAR COLLECTED PREMIUMS

    (Dollars in millions)

    Three months ended

    March 31,

    2019

    2018

    Bankers Life:

    Medicare supplement

    $

    14.3

    $

    15.4

    Long-term care

    4.4

    3.7

    Supplemental health

    1.1

    1.1

    Other health

    .2

    .2

    Life

    25.9

    29.2

    Annuity

    314.2

    249.9

    Total

    360.1

    299.5

    Washington National:

    Supplemental health and other health

    16.7

    18.4

    Life

    1.9

    1.3

    Total

    18.6

    19.7

    Colonial Penn:

    Life

    12.8

    11.9

    Total

    12.8

    11.9

    Total first-year collected premiums from segments

    $

    391.5

    $

    331.1

    TOTAL COLLECTED PREMIUMS

    (Dollars in millions)

    Three months ended

    March 31,

    2019

    2018

    Bankers Life:

    Medicare supplement

    $

    184.0

    $

    188.3

    Long-term care

    63.8

    64.8

    Supplemental health

    6.0

    5.8

    Other health

    1.5

    1.5

    Life

    113.3

    115.2

    Annuity

    315.3

    251.4

    Total

    683.9

    627.0

    Washington National:

    Supplemental health and other health

    157.0

    155.7

    Medicare supplement

    10.6

    12.5

    Life

    8.8

    7.6

    Annuity

    .4

    .4

    Total

    176.8

    176.2

    Colonial Penn:

    Life

    76.8

    74.8

    Medicare supplement and other health

    .4

    .5

    Total

    77.2

    75.3

    Long-term care in run-off:

    Long-term care

    3.6

    49.6

    Total

    3.6

    49.6

    Total collected premiums from segments

    $

    941.5

    $

    928.1

    CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

    NEW ANNUALIZED PREMIUMS FOR LIFE AND HEALTH PRODUCTS (4)

    (Dollars in millions)

    Three months ended

    March 31,

    2019

    2018

    Bankers Life:

    Medicare supplement

    $

    12.4

    $

    12.9

    Long-term care

    5.8

    5.0

    Supplemental health and other health

    1.2

    1.3

    Life

    14.1

    16.5

    Total

    33.5

    35.7

    Washington National:

    Supplemental health

    20.7

    22.0

    Life

    3.2

    1.8

    Total

    23.9

    23.8

    Colonial Penn:

    Life

    22.4

    18.6

    Total

    22.4

    18.6

    Total new annualized premiums

    $

    79.8

    $

    78.1

    ANNUITY ACCOUNT VALUES

    (Dollars in millions)

    March 31,

    2019

    2018

    Bankers Life

    $

    8,688.6

    $

    8,221.2

    Washington National

    331.9

    368.1

    Total

    $

    9,020.5

    $

    8,589.3

    BROKER DEALER AND REGISTERED INVESTMENT ADVISOR CLIENT ASSETS

    (Dollars in millions)

    Three months ended

    March 31,

    2019

    2018

    Net new client assets (a):

    Brokerage

    $

    (3.0)

    $

    12.2

    Advisory

    35.7

    50.5

    Total

    $

    32.7

    $

    62.7

    Client assets at end of period (b):

    Brokerage

    $

    861.6

    $

    806.7

    Advisory

    372.8

    219.1

    Total

    $

    1,234.4

    $

    1,025.8

    (a)

    Net new client assets includes total inflows of cash and securities into brokerage and managed advisory accounts less outflows. Inflows include interest and dividends and exclude changes due to market fluctuations.

    (b)

    Client assets include cash and securities in brokerage and managed advisory accounts.

    Bankers Life is the marketing brand of various affiliated companies of CNO Financial Group including, Bankers Life and Casualty Company, Bankers Life Securities, Inc., and Bankers Life Advisory Services, Inc. Non-affiliated insurance products are offered through Bankers Life General Agency, Inc. (dba BL General Insurance Agency, Inc., AK, AL, CA, NV, PA). Agents who are financial advisors are registered with Bankers Life Securities, Inc.

    Securities and variable annuity products and services are offered by Bankers Life Securities, Inc. Member FINRA/SIPC, (dba BL Securities, Inc., AL, GA, IA, IL, MI, NV, PA). Advisory products and services are offered by Bankers Life Advisory Services, Inc. SEC Registered Investment Adviser (dba BL Advisory Services, Inc., AL, GA, IA, MT, NV, PA). Home Office: 111 East Wacker Drive, Suite 1900, Chicago, IL 60601.

    Benefit Ratios On Major Health Lines Of Business

    Three months ended

    March 31,

    2019

    2018

    Bankers Life:

    Medicare supplement:

    Earned premium

    $191 million

    $193 million

    Benefit ratio (5)

    72.3%

    73.3%

    Long-term care:

    Earned premium

    $64 million

    $64 million

    Benefit ratio (5)

    120.6%

    116.3%

    Interest-adjusted benefit ratio (a non-GAAP measure) (6)

    77.2%

    73.9%

    Washington National:

    Supplemental health:

    Earned premium

    $156 million

    $151 million

    Benefit ratio (5)

    77.6%

    78.3%

    Interest-adjusted benefit ratio (a non-GAAP measure) (6)

    53.4%

    54.4%

    NOTES

    (1)

    Management believes that an analysis of Net income applicable to common stock before: (i) net realized investment gains or losses from sales and impairments, net of related amortization and taxes; (ii) net change in market value of investments recognized in earnings, net of taxes; (iii) fair value changes due to fluctuations in the interest rates used to discount embedded derivative liabilities related to our fixed index annuities, net of related amortization and taxes; (iv) fair value changes related to the agent deferred compensation plan, net of taxes; (v) loss related to reinsurance transaction, net of taxes; (vi) changes in the valuation allowance for deferred tax assets and other tax items; and (vii) other non-operating items consisting primarily of earnings attributable to variable interest entities, net of taxes (“Net operating income,” a non-GAAP financial measure) is important to evaluate the financial performance of the company, and is a key measure commonly used in the life insurance industry.  Management uses this measure to evaluate performance because the items excluded from net operating income can be affected by events that are unrelated to the company’s underlying fundamentals.  A reconciliation of Net operating income to Net income applicable to common stock is provided in the table on page 2.  Additional information concerning this non-GAAP measure is included in our periodic filings with the Securities and Exchange Commission that are available in the “Investors – SEC Filings” section of CNO’s website, www.CNOinc.com.

    (2)

    Book value per diluted share reflects the potential dilution that could occur if outstanding stock options were exercised, restricted stock and performance units were vested and convertible securities were converted.  The dilution from options, restricted shares and performance units is calculated using the treasury stock method.  Under this method, we assume the proceeds from the exercise of the options (or the unrecognized compensation expense with respect to restricted stock and performance units) will be used to purchase shares of our common stock at the closing market price on the last day of the period.  The dilution from convertible securities is calculated assuming the securities were converted on the last day of the period.  In addition, the calculation of this non-GAAP measure differs from the corresponding GAAP measure because accumulated other comprehensive income (loss) has been excluded from the value of capital used to determine this measure.  Management believes this non-GAAP measure is useful because it removes the volatility that arises from changes in the unrealized appreciation (depreciation) of our investments.

    (3)

    The calculation of this non-GAAP measure differs from the corresponding GAAP measure because accumulated other comprehensive income (loss) has been excluded from the value of capital used to determine this measure.  Management believes this non-GAAP measure is useful because it removes the volatility that arises from changes in the unrealized appreciation (depreciation) of our investments.

    (4)

    Measured by new annualized premium for life and health products, which includes 10% of single premium whole life deposits and 100% of all other premiums (excluding annuities).  Medicare Advantage sales are not comparable to other sales and are therefore excluded in all periods.

    (5)

    The benefit ratio is calculated by dividing the related product’s insurance policy benefits by insurance policy income.

    (6)

    The interest-adjusted benefit ratio (a non-GAAP measure) is calculated by dividing the product’s insurance policy benefits less imputed interest income on the accumulated assets backing the insurance liabilities by insurance policy income.  Interest income is an important factor in measuring the performance of longer duration health products.  The net cash flows generally cause an accumulation of amounts in the early years of a policy (accounted for as reserve increases), which will be paid out as benefits in later policy years (accounted for as reserve decreases).  Accordingly, as the policies age, the benefit ratio will typically increase, but the increase in the change in reserve will be partially offset by the imputed interest income earned on the accumulated assets.  The interest-adjusted benefit ratio reflects the effects of such interest income offset (which is equal to the tabular interest on the related insurance liabilities).  Since interest income is an important factor in measuring the performance of these products, management believes a benefit ratio, which includes the effect of interest income, is useful in analyzing product performance.  Additional information concerning this non-GAAP measure is included in our periodic filings with the Securities and Exchange Commission that are available in the “Investors – SEC Filings” section of CNO Financial’s website, www.CNOinc.com.

    Cautionary Statement Regarding Forward-Looking Statements.  Our statements, trend analyses and other information contained in this press release relative to markets for CNO Financial’s products and trends in CNO Financial’s operations or financial results, as well as other statements, contain forward-looking statements within the meaning of the federal securities laws and the Private Securities Litigation Reform Act of 1995.  Forward-looking statements typically are identified by the use of terms such as “anticipate,” “believe,” “plan,” “estimate,” “expect,” “project,” “intend,” “may,” “will,” “would,” “contemplate,” “possible,” “attempt,” “seek,” “should,” “could,” “goal,” “target,” “on track,” “comfortable with,” “optimistic,” “guidance,” “outlook” and similar words, although some forward-looking statements are expressed differently. You should consider statements that contain these words carefully because they describe our expectations, plans, strategies and goals and our beliefs concerning future business conditions, our results of operations, financial position, and our business outlook or they state other ”forward-looking” information based on currently available information. Assumptions and other important factors that could cause our actual results to differ materially from those anticipated in our forward-looking statements include, among other things: (i) changes in or sustained low interest rates causing reductions in investment income, the margins of our fixed annuity and life insurance businesses, and sales of, and demand for, our products; (ii) expectations of lower future investment earnings may cause us to accelerate amortization, write down the balance of insurance acquisition costs or establish additional liabilities for insurance products; (iii) general economic, market and political conditions and uncertainties, including the performance and fluctuations of the financial markets which may affect the value of our investments as well as our ability to raise capital or refinance existing indebtedness and the cost of doing so; (iv) the ultimate outcome of lawsuits filed against us and other legal and regulatory proceedings to which we are subject; (v) our ability to make anticipated changes to certain non-guaranteed elements of our life insurance products; (vi) our ability to obtain adequate and timely rate increases on our health products, including our long-term care business; (vii) the receipt of any required regulatory approvals for dividend and surplus debenture interest payments from our insurance subsidiaries; (viii) mortality, morbidity, the increased cost and usage of health care services, persistency, the adequacy of our previous reserve estimates, changes in the health care market and other factors which may affect the profitability of our insurance products; (ix) changes in our assumptions related to deferred acquisition costs or the present value of future profits; (x) the recoverability of our deferred tax assets and the effect of potential ownership changes and tax rate changes on their value; (xi) our assumption that the positions we take on our tax return filings will not be successfully challenged by the Internal Revenue Service; (xii) changes in accounting principles and the interpretation thereof; (xiii) our ability to continue to satisfy the financial ratio and balance requirements and other covenants of our debt agreements; (xiv) our ability to achieve anticipated expense reductions and levels of operational efficiencies including improvements in claims adjudication and continued automation and rationalization of operating systems; (xv) performance and valuation of our investments, including the impact of realized losses (including other-than-temporary impairment charges); (xvi) our ability to identify products and markets in which we can compete effectively against competitors with greater market share, higher ratings, greater financial resources and stronger brand recognition; (xvii) our ability to generate sufficient liquidity to meet our debt service obligations and other cash needs; (xviii) changes in capital deployment opportunities; (xix) our ability to maintain effective controls over financial reporting; (xx) our ability to continue to recruit and retain productive agents and distribution partners; (xxi) customer response to new products, distribution channels and marketing initiatives; (xxii) our ability to achieve additional upgrades of the financial strength ratings of CNO Financial and our insurance company subsidiaries as well as the impact of our ratings on our business, our ability to access capital and the cost of capital; (xxiii) regulatory changes or actions, including: those relating to regulation of the financial affairs of our insurance companies, such as the calculation of risk-based capital and minimum capital requirements, and payment of dividends and surplus debenture interest to us; regulation of the sale, underwriting and pricing of products; and health care regulation affecting health insurance products; (xxiv) changes in the Federal income tax laws and regulations which may affect or eliminate the relative tax advantages of some of our products or affect the value of our deferred tax assets; (xxv) availability and effectiveness of reinsurance arrangements, as well as the impact of any defaults or failure of reinsurers to perform; (xxvi) the performance of third party service providers and potential difficulties arising from outsourcing arrangements; (xxvii) the growth rate of sales, collected premiums, annuity deposits and assets; (xxviii) interruption in telecommunication, information technology or other operational systems or failure to maintain the security, confidentiality or privacy of sensitive data on such systems; (xxix) events of terrorism, cyber attacks, natural disasters or other catastrophic events, including losses from a disease pandemic; (xxx) ineffectiveness of risk management policies and procedures in identifying, monitoring and managing risks; and (xxxi) the risk factors or uncertainties listed from time to time in our filings with the Securities and Exchange Commission. Other factors and assumptions not identified above are also relevant to the forward-looking statements, and if they prove incorrect, could also cause actual results to differ materially from those projected. All written or oral forward-looking statements attributable to us are expressly qualified in their entirety by the foregoing cautionary statement. Our forward-looking statements speak only as of the date made. We assume no obligation to update or to publicly announce the results of any revisions to any of the forward-looking statements to reflect actual results, future events or developments, changes in assumptions or changes in other factors affecting the forward-looking statements.

    SOURCE CNO Financial Group

    Related Links

    http://www.CNOinc.com

    Originally Posted at CISION PR Newswire on April 29, 2019 by CNO Financial Group.

    Categories: Industry Articles
    currency